Abstract
Some 1(2H)-phthalazinone derivatives were synthesized and their chemical structures were confirmed by 1H-NMR, 13C-NMR, mass and elemental analysis. Subsequently, modified Ellman’s method was used to determine both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of the synthesized compounds. The activity results showed that compound 8c was the most active AChE inhibitor with inhibition value of 63% at 100 μM among the tested compounds. In addition, docking of the synthesized compounds into the active sites of AChE and BuChE was carried out in order to predict the binding energies and non-covalent interactions stabilizing the enzyme-ligand complexes.
Keywords: Alzheimer’s disease, 1(2H)-phthalazinone, acetylcholinesterase inhibitory activity, butyrylcholinesterase inhibitory activity, Ellman’s method, molecular docking.
Letters in Drug Design & Discovery
Title:Synthesis of Some New 1(2H)-Phthalazinone Derivatives and Evaluation of Their Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activities
Volume: 14 Issue: 2
Author(s): Burcu Kılıç, Hayrettin Ozan Gülcan, Mertcan Yalçın, Fatma Aksakal, Anatoli Dimoglo, Mustafa Fethi Şahin and Deniz Songül Doğruer
Affiliation:
Keywords: Alzheimer’s disease, 1(2H)-phthalazinone, acetylcholinesterase inhibitory activity, butyrylcholinesterase inhibitory activity, Ellman’s method, molecular docking.
Abstract: Some 1(2H)-phthalazinone derivatives were synthesized and their chemical structures were confirmed by 1H-NMR, 13C-NMR, mass and elemental analysis. Subsequently, modified Ellman’s method was used to determine both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of the synthesized compounds. The activity results showed that compound 8c was the most active AChE inhibitor with inhibition value of 63% at 100 μM among the tested compounds. In addition, docking of the synthesized compounds into the active sites of AChE and BuChE was carried out in order to predict the binding energies and non-covalent interactions stabilizing the enzyme-ligand complexes.
Export Options
About this article
Cite this article as:
Kılıç Burcu, Gülcan Ozan Hayrettin, Yalçın Mertcan, Aksakal Fatma, Dimoglo Anatoli, Şahin Fethi Mustafa and Doğruer Songül Deniz, Synthesis of Some New 1(2H)-Phthalazinone Derivatives and Evaluation of Their Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activities, Letters in Drug Design & Discovery 2017; 14 (2) . https://dx.doi.org/10.2174/1570180813666160819124611
DOI https://dx.doi.org/10.2174/1570180813666160819124611 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels
Current Alzheimer Research COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Current Rheumatology Reviews Appropriate Application of Evidence to the Care of Elderly Patients with Diabetes
Current Diabetes Reviews Reduction of Aβ Levels in the Sprague Dawley Rat After Oral Administration of the Functional g-Secretase Inhibitor, DAPT: A Novel Non- Transgenic Model for Aβ Production Inhibitors
Current Pharmaceutical Design Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment
Current Medicinal Chemistry Relevant Modulation by Ferrous Ions of N-Methyl-D-Aspartate Receptors in Ischemic Brain Injuries
Current Neurovascular Research Scutellarin Attenuates Microglia-Mediated Neuroinflammation and Promotes Astrogliosis in Cerebral Ischemia - A Therapeutic Consideration
Current Medicinal Chemistry Antiviral Treatment of Cytomegalovirus Infection
Infectious Disorders - Drug Targets Probenecid: An Emerging Tool for Neuroprotection
CNS & Neurological Disorders - Drug Targets Histone Post-translational Modifications to Target Memory-related Diseases
Current Pharmaceutical Design Inflammatory Biomarkers in AD: Implications for Diagnosis
Current Alzheimer Research Induction of RhoGAP and Pathological Changes Characteristic of Alzheimers Disease by UAHFEMF Discharge in Rat Brain
Current Alzheimer Research Low Baseline Urine Creatinine Excretion Rate Predicts Poor Outcomes among Critically Ill Acute Stroke Patients
Current Neurovascular Research Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column
Current Pharmaceutical Design Aorta Remodeling Due to Stretch or Turbulent Flow/Low Wall Shear Stress: Distinctly Different Biological Phenomena?
Current Cardiology Reviews The Effects of Psychological Stress on Depression
Current Neuropharmacology Shilajit (Mumie): Current Status of Biochemical, Therapeutic and Clinical Advances
Current Nutrition & Food Science Homocysteine: A Risk Factor in Patietns with Cardiovascular Disorders in Pakistan
Current Bioactive Compounds Obesity in the Cardiovascular Continuum
Current Clinical Pharmacology Area, Age and Gender Dependence of the Nucleoside System in the Brain: a Review of Current Literature
Current Topics in Medicinal Chemistry